Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07187596 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mortality Outcome of Controlled Hypertension

Study acronym: MOCH1
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv8
  2. Trial arms changed: 0 → 1
    • Eligibility criteria expanded, about 144 words
    • Study description shortened, about 58 words
    • Site details revised
    v7
  3. Study description shortened, about 35 wordsv6
  4. Primary completion pushed from May 18, 2026 to Dec 18, 2026
    • Study completion pushed from Jul 14, 2026 to Dec 14, 2027
    v5
  5. Enrollment target: 1000000 to 2547
    • Trial status: Recruiting to Active, Not Recruiting
    • Study description expanded, about 98 words
    • Site details revised
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jan 18, 2026 to May 18, 2026
    • Study completion date: Apr 14, 2026 to Jul 14, 2026
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
DejthidaNathaphong
4 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
This review focuses on the assumption of mortality outcome of participants remaining label hypertension care is adequately managed when pressure targets are met with both qualitative and quantitaive method.
Trial Details
NCT Number NCT07187596
Lead Sponsor DejthidaNathaphong
Conditions
(from sponsor)		 Hypertension, Morality, Death, Pre-Eclampsia, Cardiovascular Diseases, Stroke, Renal Disease, Artery Stenosis +3 more
Related terms Cardiovascular Diseases, Death, Hypertension, Kidney Diseases, Maternal Death, Pre-Eclampsia, Stroke
Enrollment 2,547 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov